Cidara

$2.27
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) As of 10:56 AM EST today

Why Robinhood?

You can buy or sell Cidara and other stocks, options, and ETFs commission-free!

About CDTX

Cidara Therapeutics, Inc. Common Stock, also called Cidara, is a biotechnology company, which engages in the discovery, development, and commercialization of novel anti-infectives. Its product pipeline includes Rezafungin and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA. The listed name for CDTX is Cidara Therapeutics, Inc. Common Stock.

CEO
Jeffrey L. Stein
Employees
68
Headquarters
San Diego, California
Founded
2012
Market Cap
99.74M
Price-Earnings Ratio
Dividend Yield
Average Volume
568.70K
High Today
$2.31
Low Today
$2.21
Open Price
$2.27
Volume
35.29K
52 Week High
$4.45
52 Week Low
$1.30

Collections

CDTX Earnings

-$0.60
-$0.37
-$0.15
$0.08
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 4, After Hours

You May Also Like